Douglas Stearn

The U.S. Food and Drug Administration sent warning letters Tuesday to LifeVantage Corp (NASDAQ: LFVN) and 13 other companies engaged in the illegal sale of more than 65 products purported but unproven to prevent, diagnose or treat cancer. The regulatory agency listed LifeVantage’s Protandim...